| Entry |
|
| Name |
NivobotulinumtoxinA (USAN) |
| Class |
Musculo-skeletal system agent
DG02029 Muscle relaxant
DG01696 Peripherally-acting muscle relaxant
DG03117 Nondepolarizing neuromuscular blocking agent
|
| Remark |
| Product (DG00772): | D00783<JP/US> D02735<US> D11405<US> D08957<US> D10012<JP/US> D10949<US> |
|
| Efficacy |
Skeletal muscle relaxant |
| Comment |
Treatment of glabellar lines and lateral canthal lines
|
| Interaction |
|
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
M MUSCULO-SKELETAL SYSTEM
M03 MUSCLE RELAXANTS
M03A MUSCLE RELAXANTS, PERIPHERALLY ACTING AGENTS
M03AX Other muscle relaxants, peripherally acting agents
M03AX01 Botulinum toxin
D10961 NivobotulinumtoxinA (USAN)
Drug groups [BR:br08330]
Musculo-skeletal system agent
DG02029 Muscle relaxant
DG01696 Peripherally-acting muscle relaxant
DG03117 Nondepolarizing neuromuscular blocking agent
DG00772 Botulinum toxin
D10961 NivobotulinumtoxinA
Drug groups [BR:br08330]
Musculo-skeletal system agent
DG02029 Muscle relaxant
DG01696 Peripherally-acting muscle relaxant
DG03117 Nondepolarizing neuromuscular blocking agent
DG00772 Botulinum toxin
|
| Other DBs |
|
| LinkDB |
|